Translating Innovative Science into Compassionate, Patient-Centric Care
Saint John’s Cancer Institute is renowned for advancing therapeutics, translational science, and establishing standards of care. We foster robust fellowship programs, implement and initiate clinical trials, and collaborate with academic and industry partners worldwide.
Read MoreInnovation Starts Here
Saint John’s Cancer Institute (SJCI) is a pioneer in drug discovery, therapeutics, clinical trials, and research. SJCI established the Sentinel Lymph Node Biopsy under the late Dr. Donald L. Morton, which has become the standard of lymph node care for melanoma and breast cancer worldwide.
Today, our patients continue to have access to innovative treatments, therapeutics, and trials. We are at the forefront of understanding the biology of cancer as well as expanding treatment for under-served communities.
Learn More
White Button Mushroom Prostate Cancer Clinical Trial
A novel approach aimed at early prostate cancer progression – Saint John’s Cancer Institute is now enrolling patients for this trial.
“We have had prior evidence that it may have anti-cancer activity in patients with early-stage prostate cancer.”
– Przemyslaw Twardowski, M.D., Principle Investigator
Learn more about trial eligibility.
Dr. Santosh Kesari, Principal Investigator, Oversees Open Neurological & Brain Cancer Clinical Trials
Dr. Santosh Kesari of the Pacific Neuroscience Institute is the principal investigator for more than a dozen clinical trials, of which 8 are brain tumor-related.
Dr. Kesari is the Chair and Professor of the Department of Translational Neuro-oncology and Neurotherapeutics at Saint John’s Cancer Institute.
BLOG: Clinical Trials for Patients with Brain Tumors and Diseases in Santa Monica, California
What is it like to Participate in a Clinical Trial?
Mark Perzely was diagnosed with small-cell carcinoma—a rare and aggressive cancer that developed in his bladder.
“Once small-cell spreads, it won’t stop, and there are no approved treatments,” according to Mark’s video testimonial.
Read more about Mark’s story and listen to his outlook several years after the trial.
BLOG & VIDEO (5:43): What is it like to Participate in a Clinical Trial?
New Precision Medicine Breast Cancer Clinical Trials Open, and Actively Recruiting
Dr. Parvin Peddi, Director of Breast Medical Oncology and Associate Professor of Medical Oncology, is the Principal Investigator in 4 New, Targeted Therapy Clinical Trials for Breast Cancer.
BLOG: New Precision Medicine Breast Cancer Clinical Trials Open, and Actively Recruiting.
Listen to Dr. Melanie Goldfarb discuss thyroid health, thyroid cancer, and treatment innovations including Radio Frequency Ablation (RFA).
Melanie Goldfarb, M.D., M.Sc., FACS, FACE, is the Director of the Center for Endocrine Tumors and Disorders, and a Professor of Surgical Oncology
BLOG & PODCAST (28:49): Dr. Melanie Goldfarb discusses thyroid health, cancer, and treatment innovations including Radio Frequency Ablation (RFA).
Hosted by Mary Renouf
A Legacy of Research Excellence
“He was ahead of his peers in anticipating the genetics era of cancer research, for decades he carefully maintained archival specimen resource for correlative translational studies.”
– Laura Morton Rowe, Chief Human Resources Officer, Saint John’s Health Center
Providence Saint John’s Health Center contributes $2 million to Stand Up To Cancer Dream Team’s Effort to Reduce Disparities in Colorectal Cancer Screenings
Co-leading the Dream Team is Dr. Anton Bilchik
“This team has a tremendous opportunity to create solutions that can be used as national models for integrated colorectal cancer outreach and screening.”
– Anton Bilchik, M.D.
Featured Publications
